| Sub Cat. No. |
Molecular Weight |
Glycan Name |
Functional Group |
Inquiry |
|
X25-05-YM712-1 |
PEG 350 Da |
Lentinan |
RVG29 |
Inquiry
|
|
X25-05-YM712-2 |
PEG 550 Da |
Lentinan |
RVG29 |
Inquiry
|
|
X25-05-YM712-3 |
PEG 750 Da |
Lentinan |
RVG29 |
Inquiry
|
|
X25-05-YM712-4 |
PEG 1 kDa |
Lentinan |
RVG29 |
Inquiry
|
|
X25-05-YM712-5 |
PEG 2 kDa |
Lentinan |
RVG29 |
Inquiry
|
|
X25-05-YM712-6 |
PEG 3 kDa |
Lentinan |
RVG29 |
Inquiry
|
|
X25-05-YM712-7 |
PEG 4 kDa |
Lentinan |
RVG29 |
Inquiry
|
|
X25-05-YM712-8 |
PEG 5 kDa |
Lentinan |
RVG29 |
Inquiry
|
|
X25-05-YM712-9 |
PEG 10 kDa |
Lentinan |
RVG29 |
Inquiry
|
|
X25-05-YM712-10 |
PEG 20 kDa |
Lentinan |
RVG29 |
Inquiry
|
Properties
Description
Lentinan-PEG-RVG29 peptide, also known as RVG29-lentinan, represents a composite biomaterial formed by covalently linking lentinan—a triple-helical β-1,3-1,6-glucan with immune-activating properties—to the RVG29 peptide through PEG-based molecular bridges. This engineered structure combines lentinan's macrophage-modulating effects with DPPS-mediated membrane fusion capabilities, establishing a bifunctional therapeutic agent.
Glycan Structure
Its glycan structure is a β-(1→3)-linked d-glucose backbone with β-(1→6)-glucosyl side branches.
Source
Chemical synthesis
Impurities
No visible impurities to the naked eye.
Solubility
This product is soluble in most organic solvents, such as DCM, DMF, DMSO, and THF, and exhibits excellent solubility in water.
Identity
Confirmed by NMR.
Applications
Lentinan-PEG-RVG29 peptide can be used for its potential to enable neuron-specific targeting through RVG29 peptide conjugation for blood-brain barrier transport studies.
